NM_002880.4(RAF1):c.845G>A (p.Arg282Gln) AND RASopathy

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 4, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001216616.8

Allele description [Variation Report for NM_002880.4(RAF1):c.845G>A (p.Arg282Gln)]

NM_002880.4(RAF1):c.845G>A (p.Arg282Gln)

Gene:

RAF1:Raf-1 proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3p25.2

Genomic location:

Preferred name:

NM_002880.4(RAF1):c.845G>A (p.Arg282Gln)

HGVS:

NC_000003.12:g.12600405C>T
NG_007467.1:g.68775G>A
NM_001354689.3:c.905G>A
NM_001354690.3:c.845G>A
NM_001354691.3:c.602G>A
NM_001354692.3:c.602G>A
NM_001354693.3:c.746G>A
NM_001354694.3:c.662G>A
NM_001354695.3:c.503G>A
NM_002880.4:c.845G>AMANE SELECT
NP_001341618.1:p.Arg302Gln
NP_001341619.1:p.Arg282Gln
NP_001341620.1:p.Arg201Gln
NP_001341621.1:p.Arg201Gln
NP_001341622.1:p.Arg249Gln
NP_001341623.1:p.Arg221Gln
NP_001341624.1:p.Arg168Gln
NP_002871.1:p.Arg282Gln
NP_002871.1:p.Arg282Gln
LRG_413t1:c.845G>A
LRG_413t2:c.905G>A
LRG_413:g.68775G>A
LRG_413p1:p.Arg282Gln
LRG_413p2:p.Arg302Gln
NC_000003.11:g.12641904C>T
NM_002880.3:c.845G>A
NR_148940.3:n.1176G>A
NR_148941.3:n.1176G>A
NR_148942.3:n.1176G>A

Protein change:

R168Q

Links:

dbSNP: rs752713997

NCBI 1000 Genomes Browser:

rs752713997

Molecular consequence:

NM_001354689.3:c.905G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354690.3:c.845G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354691.3:c.602G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354692.3:c.602G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354693.3:c.746G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354694.3:c.662G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001354695.3:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_002880.4:c.845G>A - missense variant - [Sequence Ontology: SO:0001583]
NR_148940.3:n.1176G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148941.3:n.1176G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148942.3:n.1176G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: RASopathy
Synonyms:: rasopathies; Noonan spectrum disorder
Identifiers:: MONDO: MONDO:0021060; MedGen: C5555857

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001388421	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 4, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001388421

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 4, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001388421.5

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 282 of the RAF1 protein (p.Arg282Gln). This variant is present in population databases (rs752713997, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RAF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 503548). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RAF1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine